1. Pelkonen M, Tukiainen H, Tervahauta M, Notkola IL, Kivela SL, Salorinne Y, Nissinen A: Pulmonary function, smoking cessation and 30 year mortality in middle aged Finnish men. In Thorax. Volume 55. ENGLAND ; 2000:746–750.
2. Knuiman MW, James AL, Divitini ML, Ryan G, Bartholomew HC, Musk AW: Lung function, respiratory symptoms, and mortality: results from the Busselton Health Study. In Ann Epidemiol. Volume 9. UNITED STATES ; 1999:297–306.
3. Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM: Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. In Br Med J. Volume 313. ENGLAND ; 1996:711–5.
4. Grol MH, Gerritsen J, Vonk JM, Schouten JP, Koeter GH, Rijcken B, Postma DS: Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years. A 30-year follow-up study. In Am J Respir Crit Care Med. Volume 160. UNITED STATES ; 1999:1830–1837.
5. Maritz GS, Morley CJ, Harding R: Early Developmental Origins of Impaired Lung Structure and Function. In Early Hum Dev. Volume 81. Ireland ; 2005:763–771.